Nectar Life Sciences Limited - Company Profile

Q: Who are the current directors of Nectar Life Sciences Limited?

The current directors of Nectar Life Sciences Limited are Rupinder Tewari, Sanjiv Goyal, Indu Pal Kaur, Kuldip Kumar Bhasin, Sushil Kapoor, Surulichamy Senthilkumar, Sanjaymohan Singh Rawat, Sushil Kapoor.

It is a pharma public limited company based in Derabassi, Punjab, India, established in 1995.

1995 Derabassi, Punjab, India Active

Last Updated: December 18, 2025

Access Report

About Nectar Life Sciences Limited

Nectar Life Sciences Limited, a active public limited company, was established on 27 June 1995 in Derabassi, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232PB1995PLC016664. Registered under ROC Roc Chandigarh. it is listed on BSE: 532649 and NSE: NECLIFE. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹22.43 Cr.

Formerly known as Surya Medicare Limited. It upholds a compliant status. In 2025, it reported revenue of ₹1,674.97 Cr and a net worth of ₹956.11 Cr. Employing 1,814 professional, Its leadership includes Rupinder Tewari (Director), Sanjiv Goyal (Managing Director), Indu Pal Kaur (Director). Past directors included Ajay Swaroop, Rupinder Tewari, Raman Kapur. It holds ₹6.05 M open charges and ₹6,249.44 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 5, Sl Enclave, Behind Sohi Hp Gas Agency, Barwala Road, Derabassi, Distt. S.A.S Nagar,, Derabassi, Punjab, 140507.

Company Details

CIN/LLPIN
L24232PB1995PLC016664
Registration Number
016664
Incorporation Date
27 June 1995
Authorized Capital
₹35.00 Cr
Paid-Up Capital
₹22.43 Cr
ROC Code
Roc Chandigarh
Listing Status
Listed (BSE: 532649, NSE: NECLIFE)
Company Status
Active

Key Metrics

Authorised Capital ₹ 35.00 Cr as on 18-12-2025
Paid Up Capital ₹ 22.43 Cr as on 18-12-2025
Company Age 30 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 6.05 M as on 18-12-2025
Satisfied Charges ₹ 6,249.44 Cr as on 18-12-2025
Revenue Growth **** -1.39% (FY 2025)
Profit Growth **** -2372.71% (FY 2025)
Ebitda **** -117.28% (FY 2025)
Net Worth -10.58% (FY 2025)
Total Assets -6.56% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Nectar Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nectar Life Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rupinder Tewari	Director	11 Feb 2019	Current
Sanjiv Goyal	Managing Director	27 Jun 1995	Current
Indu Pal Kaur	Director	02 Aug 2022	Current
Kuldip Kumar Bhasin	Director	21 Sep 2021	Current
Surulichamy Senthilkumar	Whole-Time Director	01 Jun 2025	Current
Sushil Kapoor	Whole-Time Director	04 Dec 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	29 Sep 2019	Past
Pramod Abcsdd	Additional Director	28 Sep 2019	Past
Pramod Abcsdd	Additional Director	29 Sep 2010	Past
Pramod Abcsdd	Director	01 Oct 2009	Past
Pramod Abcsdd	Director	22 Jan 2007	Past
Pramod Abcsdd	Additional Director	28 Sep 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nectar Life Sciences.

Nectar Life Sciences Limited, for the financial year ended 2025, experienced Minor drop in revenue, with a 1.39% decrease. The company also saw a substantial fall in profitability, with a 2372.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.58%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-1.39%

*******

Revenue from Operations

*******

-0.74%

*******

Total Assets

*******

-6.56%

*******

Profit or Loss

*******

-2372.71%

*******

Net Worth

*******

-10.58%

*******

EBITDA

*******

-117.28%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nectar Life Sciences?

In 2024, Nectar Life Sciences had a promoter holding of 44.35% and a public holding of 55.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹6,047,200.00

Satisfied Charges

₹62,494,370,902.00

Charges Breakdown by Lending Institutions

Others : 1377.64 Cr
Sbicap Trustee Company Limited : 1338.35 Cr
Punjab National Bank : 790.10 Cr
State Bank Of India : 771.01 Cr
Export-Import Bank Of India : 430.00 Cr
Others : 1542.33 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Dec 2023	Hdfc Bank Limited	₹6.05 M	Satisfied
28 Jun 2022	Hdfc Bank Limited	₹2.00 M	Satisfied
01 Dec 2021	Hdfc Bank Limited	₹2.00 M	Satisfied
14 Jul 2021	Hdfc Bank Limited	₹0.60 M	Satisfied
21 Jun 2021	Sbicap Trustee Company Limited	₹1,338.35 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nectar Life Sciences?

Nectar Life Sciences has a workforce of 1814 employees as of Nov 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nectar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nectar Life Sciences

Recent Activity within the Organization

Director Appointment

Progress on Sushil Kapoor was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 04 Dec 2025 & has been associated with this company since 2 months 3 days . was documented.
04 Dec 2025
Charges

Progress on A charge registered on 27 Dec 2023 via Charge ID 100841946 with Hdfc Bank Limited was fully satisfied on 14 Nov 2025. was documented.
14 Nov 2025
Charges

A charge registered on 21 Jun 2021 via Charge ID 100458233 with Sbicap Trustee Company Limited was fully satisfied on 21 Oct 2025. was recorded as a recent event.
21 Oct 2025
Annual General Meeting

The activity Nectar Life Sciences Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
29 Sep 2025
Charges

A charge registered on 28 Jun 2022 via Charge ID 100593892 with Hdfc Bank Limited was fully satisfied on 01 Aug 2025. was recorded as a recent event.
01 Aug 2025
Charges

A charge registered on 01 Dec 2021 via Charge ID 100511693 with Hdfc Bank Limited was fully satisfied on 03 Jul 2025. was recorded as a recent event.
03 Jul 2025

Explore recent activity and updates - View Recent Activity